A “Positive” Primary Outcome for PEITHO
Yet, by “positive”, as we all too often see, the underlying data comes with a surprise twist. The Pulmonary Embolism Thrombolysis (PEITHO) trial evaluates single-dose tenecteplase added to conventional heparin therapy for the treatment of “intermediate risk” acute pulmonary embolism. This includes patients with pulmonary embolism, right ventricular dysfunction on imaging, and elevated cardiac biomarkers. … Continue reading “A “Positive” Primary Outcome for PEITHO”